Mark Wagner Email & Phone Number

Louisville, Ky, Us

Responsible for leading the strategy, operations, and general management of the organization to achieve financial objectives, expand distribution, ensure regulatory compliance, and drive shareholder value. Manage team of 6 FTEs.• Owned P&L responsibility for the company, including budgeting/forecasting, accounting & cash management, investor relations, and fiscal reporting to the Board of Directors.• Drove 10x increase in revenue from 2019 to 2020-21 as a result of negotiating a contract manufacturing agreement with 3rd party medical device distributor.• Doubled production capacity to meet increased demand from distribution partnership, including significant expansion of cleanroom and lab space to increase production and R&D efficiency.• Initiated vertical integration project to develop & manufacture proprietary calcium phosphate, securing supply certainty while reducing cost by 63% for this core raw material.• Drove product development to treat joint osteoarthritis via minimally invasive surgical procedure; has potential to reverse progression to joint replacement; represents a multibillion-dollar market opportunity.• Established Vivorté’s first Surgeon Advisory Board (SAB) to provide guidance on product development and support for product launches.• Redesigned and/or created sales training tools, collateral material and clinical publications supporting unique selling proposition for Vivorté products; led sales training and surgeon visits for reps in the field.• Closed over $5 million in incremental equity investment in Vivorté, including development of pitch materials and presentations to the investor community.• Administered HR, including updating or creating policies covering hiring, benefits, codes-of-conduct, etc.• Instituted Vivorté’s first bonus plan in 2020 to recognize and reward employees for meeting or exceeding performance expectations.

Louisville, Ky, Us

Led marketing and sales of line of orthopedic biomaterials designed to improve bone strength while expediting the healing process. Scope included P&L accountability, strategic planning, sales leadership, training, product development, marketing and branding. Managed a department of 2.

Nashville, Tn, Us

Responsible for marketing and distribution of $24 million portfolio of orthobiologic implants designed to restore health and enhance quality of life for patients undergoing spine, trauma, general orthopedic, sports medicine and dental surgeries. Scope included P&L accountability, strategic planning, sales leadership, training, product development, marketing and branding. Managed a department of 13. • Grew revenue by a 15% compound annual growth rate since 2011 in a healthcare market facing cost containment challenges as a result of an evolving reimbursement environment. • Two thirds of the way through fiscal 2017, drove year-to-date revenue 20% over budget. • Negotiated and executed 10 new private label contracts, plus 12 contracts with independent distributors, which account for approximately 26% of current top-line revenue. • Developed comprehensive training programs for direct and distributor sales channels by providing the education, skills and tools to effectively penetrate the spine, trauma, sports medicine, foot & ankle and general orthopedic markets. • Created marketing collateral to support sales initiatives, including product catalogs, product launch training and tools, sales demo materials, and the company’s first line of branded demineralized bone products.• Led the implementation of a robust product development process to increase efficiency, reduce redundancy, promote quality, and ensure that projects remain on track and on budget. • Initiated quarterly employee performance evaluation process to track progress, recalibrate goals and take corrective action with sufficient frequency to impact the fiscal year. Process has subsequently been adopted corporate-wide.

Conshohocken, Pa, Us

Responsible for $40 million pharmacy automation technologies that support patient safety and operational efficiency within the hospital, retail and long-term care pharmacy settings. Scope includes the product life cycle, market segment strategies, product development, branding, training and support. Manage 3 direct reports.• Led design and development of new MedSelect line of automated dispensing cabinets, reestablishing presence and momentum in $1 billion market.• Extended OptiFill vial filling technology to lower volume platforms, opening up new opportunities in half-billion dollar hospital and mail order markets.• Established three-year product roadmap, with projects prioritized based on strategic value, to enable the business to better manage limited financial and human resources.• Created marketing plan template currently used throughout Product Management to identify market dynamics, establish product positioning and delineate tactics by market segment.

Responsible for $82 million vascular and oncology product line. Scope included product development, new/upgraded product launches, brand strategy, collaterals, and new product training. Managed 3 direct reports.• Generated 15%+ revenue growth, exceeding growth of market, for two consecutive years. • Built the Angiotech Interventional brand and increased market awareness through trademark and marketing collateral design, trade show sponsorship, packaging, and presentation materials.• Penetrated the $80 million chronic dialysis market with the mid-2008 launch of the HemoStream catheter, generating six-month revenue 19% over plan.• Prepared Option IVC for ’09 product launch, addressing the $200 million Inferior Vena Cava market.• Built the 2007 National Sales meeting agenda within 30 days of joining the organization. This included: new product rollout, product training, promotional premiums and teambuilding exercises.• Increased lead generation 360% (23 to 106 leads) at the Cardiovascular and Interventional Radiological Society of Europe meeting through a variety of booth, product, and people strategies.

Alachua, Fl, Us

Targeted spinal and orthopedic manufacturers as potential OEM partners to expand allograft or xenograft capacity. Identified emerging technologies that supported long-term growth strategy.• Negotiated and executed two agreements with $4 million in projected first-year revenues.• Identified and closed the company’s first xenograft manufacturing and distribution partnership.• Generated $1.5 million in incremental 2006 revenue by divesting inactive RTI inventory through an alternative tissue processor.

Alachua, Fl, Us

Responsible for $13 million Orthopedic business. Managed product development, marketing, and distribution of allograft tissue and demineralized bone paste used in general orthopedic procedures.• Re-energized account relationship with Exactech, one of RTI’s strategic corporate partners, to generate 6% revenue growth in a market growing at half that rate.• Developed and launched a reformulated line of orthopedic bone paste ($160 million market), improving the handling characteristics to remedy a major surgeon complaint.

Alachua, Fl, Us

Responsible for strategy and program development to expand tissue donation opportunities. 5 direct reports.• Developed first ever three-year strategic plan for Donor Services, incorporating statistical analysis and performance metrics to fully evaluate new business opportunities.• Built marketing foundation for stand-alone donor services organization. Over two years, growth in donors increased an average of 14%.• Pioneered funeral home recovery program, which comprised 25% of RTI’s sourced material within three years.

Responsible for $100 million Black & Decker branded Cooking division. 2 direct reports.• Increased revenue 22% over two-years by developing and launching products in twelve segments, positioning the company as a full-line cooking supplier.• Reversed share erosion in Toaster Ovens, incorporating a good-better-best product development strategy. Dollar share rebounded 7% in year one.

Responsible for $320 million Men’s Razor division and $33 million marketing budget. 2 direct reports.• Grew revenues $50 million+ in 2-year period through a multimillion-dollar marketing campaign to encourage trial and conversion among young male blade users.• Launched revolutionary Advantage shaver line in 1998, encouraging trial of product's technological "advantage" to achieve launch revenue 200% above budget.• Designed 1998 NHL All-Star Game promotion, leveraging NHL’s young male demographic to increase relevance of Norelco brand with this emerging shaving segment.

Created proprietary marketing programs targeting retailers to promote financial inventory lending and improve customer retention.

Responsible for marketing financial information products to commercial banks doing business with the Federal Reserve Bank of Chicago.

Developed distribution plans and marketing programs intended to maximize revenue and profitability for four flagship season catalogs.

Mba, Marketing & Management Policy

Ba, History & Economics